2002
DOI: 10.1046/j.1471-4159.2002.01267.x
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of neurogenesis by amyloid β‐peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease

Abstract: Neurogenesis occurs in the adult mammalian brain and may play roles in learning and memory processes and recovery from injury, suggesting that abnormalities in neural progenitor cells (NPC) might contribute to the pathogenesis of disorders of learning and memory in humans. The objectives of this study were to determine whether NPC proliferation, survival and neuronal differentiation are impaired in a transgenic mouse model of Alzheimer's disease (AD), and to determine the effects of the pathogenic form of amyl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

27
299
4
10

Year Published

2004
2004
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 433 publications
(343 citation statements)
references
References 92 publications
27
299
4
10
Order By: Relevance
“…Microglial cells recruited to the injury site showed elevated increased P2X7 receptor expression, as observed in animal models and human patients [83,84]. P2X7 receptor activation by elevated ATP concentration promotes the secretion of the cytokines by microglial cells and activated oxygen species, increasing inflammation and stimulating Aβ-plaque formation, which also stimulates ATP liberation [82,85,86]. Furthermore, the P2Y1 subtype is expressed in AD typical structures such as Aβ plaques and neurofibrillary tangles, and receptor immunostaining was notably high in AD brain suggesting that P2Y1 receptors may participate in signaling events triggering neurodegenerative processes [61,81,82].…”
Section: Alzheimer's Diseasementioning
confidence: 86%
“…Microglial cells recruited to the injury site showed elevated increased P2X7 receptor expression, as observed in animal models and human patients [83,84]. P2X7 receptor activation by elevated ATP concentration promotes the secretion of the cytokines by microglial cells and activated oxygen species, increasing inflammation and stimulating Aβ-plaque formation, which also stimulates ATP liberation [82,85,86]. Furthermore, the P2Y1 subtype is expressed in AD typical structures such as Aβ plaques and neurofibrillary tangles, and receptor immunostaining was notably high in AD brain suggesting that P2Y1 receptors may participate in signaling events triggering neurodegenerative processes [61,81,82].…”
Section: Alzheimer's Diseasementioning
confidence: 86%
“…It should be noted that one consistent finding in those models is that the deposition of Aβ is dramatically increased in the brain. There is evidence that the deposition of Aβ itself may disrupt neurogenesis (Haughey, et al, 2002, Zhang, et al, 2007. Therefore, it might be possible that the changes in neurogenesis were, at least partially, dependent on the amount of Aβ deposition.…”
Section: Discussionmentioning
confidence: 99%
“…The enriched environment (EE)-induced proliferation and neuronal differentiation of hippocampal progenitor cells in mice harboring the FAD-linked human PS1 variant transgenes (PS1ΔE9 or PS1M146L) was significantly impaired, which appeared to involve soluble factors released from microglia (Choi et al, 2008). Similarly, the proliferation and survival of neural progenitor cells were reduced in transgenic mice expressing a mutated form of APP (APPswe) that causes early-onset FAD (Haughey et al, 2002). An agedependent decrease in SGZ proliferation was also observed in mice transgenic for human V717F mutant APP, a model of AD with age-dependent accumulation of Aβ42-containing plaques (Donovan et al, 2006).…”
Section: Neurogenesis Under Pathological Conditionsmentioning
confidence: 99%